Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....
SICAGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sicagen India Ltd has informed BSE that its Board of Directors will meet on Friday, 30 January 2026, to consider and approve the un-audited financial results (both standalone and consolidated) for the quarter and nine months ended 31 December 2025. The company is complying with SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulation 29 by giving advance notice of the meeting. The trading window for designated persons and their immediate relatives will remain closed from 1 January 2026 until 48 hours after the results are declared, in line with insider trading regulations. No financial figures, projections, or business commentary have been disclosed in this filing — the actual numbers will come when the results are announced on 30 January 2026.
This is a routine regulatory intimation with no direct impact on the stock. Investors should watch for the actual Q3 results on 30 January 2026 for any meaningful performance update. Until then, expect low information flow and limited price-moving news from the company.